Wed, Nov 02, 2022
Sun Pharma share price: Post second quarter results, brokerages have revised the target price on the stock
More >
Wed, Feb 14, 2018
The company posted consolidated profit after tax (PAT) of Rs 365.39 crore - declining by 75.17% compared to Rs 1,471.82 crore in the corresponding period of the previous year.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
